Clinical Trials on Chronic Graft-versus-host Disease (cGVHD) in New Zealand
Total 645 results
-
EquilliumBiocon LimitedRecruitingGraft Versus Host Disease | GVHD | aGVHD | Acute-graft-versus-host Disease | Acute GVHDUnited States, Korea, Republic of, Germany, Israel, Spain, Belgium, Italy, Australia, France, Canada, Portugal, New Zealand
-
EquilliumBiocon LimitedRecruitingGVHD | GVHD, Acute | aGVHD | Acute-graft-versus-host DiseaseUnited States
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompleted
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
-
Columbia UniversityIncyte CorporationTerminatedGraft Vs Host Disease | Steroid Refractory GVHDUnited States
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)United States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
AmgenCompletedChronic Graft-versus-Host Disease (cGVHD)Australia
-
Regimmune CorporationCompletedGraft Vs Host Disease | Graft-versus-host-disease | Acute-graft-versus-host Disease | Prevention of aGVHDUnited States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
John LevineCompletedGVHD | Low Risk Acute Graft-versus-host Disease | Graft-versus-host-diseaseUnited States
-
NYU Langone HealthCompleted
-
CSL BehringNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsActive, not recruitingGraft Versus Host Disease (GVHD)United States
-
University of RochesterWithdrawnActive Chronic Graft Versus Host DiseaseUnited States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)Belgium, Italy, Spain, Saudi Arabia, Turkey, United Kingdom, Germany, Greece, Canada, Austria, France, Israel, Netherlands, Sweden, Switzerland, Korea, Republic of, Bulgaria, Japan, Norway, Czechia, Russian Federation, Jordan, Hungary, Ind... and more
-
M.D. Anderson Cancer CenterCompleted
-
University of RochesterTerminatedChronic Graft Versus Host DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingGraft-Versus-Host Disease | GVHD | UndefinedUnited States
-
Yale UniversityTerminatedGraft Versus Host DiseaseUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States, Canada, Australia, Switzerland, Puerto Rico, New Zealand
-
Incyte CorporationRecruiting
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
MallinckrodtParexelCompletedChronic Graft Versus Host DiseaseUnited States, France, Germany, United Kingdom, Spain, Italy, Austria, Hungary
-
MallinckrodtCompletedGraft-versus-Host DiseaseUnited States, Australia, France, Italy, Austria, Germany, Portugal, Slovakia, Spain, Switzerland, Turkey, United Kingdom
-
ActelionTerminatedChronic Graft Versus Host DiseaseUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Graft Versus Host DiseaseUnited States, Australia, Austria, Canada, China, Croatia, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Singapore, Spain, Taiwan
-
Gilead SciencesTerminatedChronic Graft Versus Host DiseaseSpain, Korea, Republic of, United States, Germany, Canada, France, United Kingdom
-
Ann & Robert H Lurie Children's Hospital of ChicagoAstex Pharmaceuticals, Inc.CompletedGraft vs Host DiseaseUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedChronic Graft-versus-host-diseaseUnited States
-
McMaster UniversitySanofi; Ozmosis Research Inc.; Cell Therapy Transplant CanadaRecruitingAcute Leukemia | Myelodysplasia | Chronic Graft-versus-host-diseaseCanada, Australia
-
Memorial Sloan Kettering Cancer CenterIncyte Corporation; Hackensack Meridian HealthCompletedNon-sclerotic Cutaneous Chronic Graft-versus-host DiseaseUnited States
-
NYU Langone HealthRecruiting
-
NYU Langone HealthActive, not recruitingGraft-versus-host DiseaseUnited States
-
Alexion PharmaceuticalsTerminatedAcute Graft-Versus-Host Disease | GIGVHDUnited States, France
-
Genentech, Inc.TerminatedAcute Graft-versus-host DiseaseUnited States, Canada
-
Mesoblast, Inc.No longer availableGraft-Versus-Host DiseaseUnited States
-
Genentech, Inc.Completed
-
Jazz PharmaceuticalsCompletedAcute-graft-versus-host Disease | Graft-versus-host DiseaseUnited States, Belgium, United Kingdom, Greece, Germany, Spain, France, Italy, Austria, Canada, Bulgaria, Croatia, Poland, Portugal
-
Mesoblast, Inc.Quintiles, Inc.CompletedGrade B Acute Graft Versus Host Disease | Grade C Acute Graft Versus Host Disease | Grade D Acute Graft Versus Host DiseaseUnited States
-
Northwell HealthWithdrawnAcute GVH DiseaseUnited States
-
Cynata Therapeutics LimitedCompletedGraft vs Host DiseaseAustralia, United Kingdom
-
MallinckrodtPRA Health SciencesTerminatedAcute Graft-versus-Host DiseaseUnited States, Canada, Germany, United Kingdom, Australia, Austria, Belgium, Italy, France, Netherlands, Switzerland
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseKorea, Republic of, United States, Spain, Taiwan, France, Singapore, Belgium, Germany, Italy, Canada, Israel, Australia, United Kingdom, Greece, Poland, Portugal
-
Fred Hutchinson Cancer CenterAstraZenecaRecruitingHematopoietic and Lymphoid Cell Neoplasm | Recurrent Moderate-Severe Chronic Graft Versus Host DiseaseUnited States
-
Incyte CorporationTerminatedAcute Graft-versus-host DiseaseUnited States, Spain, France, Italy, United Kingdom, Germany
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedGraft Versus Host DiseaseUnited States
-
John LevineBiogenCompletedAcute Graft Versus Host DiseaseUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedGraft Versus Host DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterMillennium: The Takeda Oncology CompanyCompletedMyeloid Hematologic Malignancy | Lymphoid Hematologic MalignancyUnited States